Cargando…

600. The Effect of Medication-Assisted Treatment on Completion Rates of Outpatient Parenteral Antibiotic Therapy

BACKGROUND: Injection drug use is a nationwide epidemic associated with an increased risk of invasive Staphylococcus aureus (S. aureus) infections. Medication-assisted treatment (MAT) is effective in reducing substance use and increasing adherence to inpatient medical therapy in persons with injecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greco, Christian S, Sobhanie, Mohammad Mahdee, Coe, Kelci E, Hebert, Courtney, Williams, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644438/ http://dx.doi.org/10.1093/ofid/ofab466.798

Ejemplares similares

272. Clinical Outcomes with Continuation of Combination Antibiotic Therapy versus De-escalation to Monotherapy for Patients with MRSA Bacteremia
por: Nichols, Courtney, et al.
Publicado: (2020)

318. Description of Patients Readmitted within 30 Days from COVID-19 Hospitalization
por: Al-Saadi, Mahmoud, et al.
Publicado: (2021)

367. Clinical Characteristics and Outcomes in Patients with Pneumonia secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
por: Nichols, Courtney, et al.
Publicado: (2020)

2413. Drug Use Associated vs Non-Drug Use Associated Endocarditis in an Academic Center from 2012-2017
por: Sobhanie, Mohammad Mahdee, et al.
Publicado: (2023)

600. Decreased Hospital Readmission After Programmatic Strengthening of an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program
por: Agnihotri, Gaurav, et al.
Publicado: (2020)

480. Redefining the Epidemiologic Profile of Histoplasmosis from 2011 to 2021 in Central Ohio
por: Hofmann, JustIn, et al.
Publicado: (2022)

Clinical Outcomes With Definitive Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia With Retained Daptomycin and Ceftaroline Combination Therapy vs De-escalation to Monotherapy With Vancomycin, Daptomycin, or Ceftaroline
por: Nichols, Courtney N, et al.
Publicado: (2021)

197. Infective Endocarditis Over a Five-Year Period in an Academic Teaching Center: The Validity of ICD Codes vs. Manual Chart Review
por: Haden, Michael, et al.
Publicado: (2019)

217. Broad Spectrum Antibiotic use in Outpatient Parenteral Antibiotic Therapy (OPAT): Opportunities for Antibiotic Stewardship
por: Brenon, Jessa R, et al.
Publicado: (2020)

1900. Disseminated and Extrapulmonary Nontuberculous Mycobacteria (NTM): Disease Management, Adverse Treatment Reactions, and Outcomes
por: Wang, Heather, et al.
Publicado: (2023)

553. Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Treatment with Monoclonal Antibody Therapy (MAT) in the Outpatient Setting
por: Nichols, Courtney, et al.
Publicado: (2021)

591. A Model for assessing staffing needs for an Outpatient Parenteral Antibiotic Therapy (OPAT) program
por: Munsiff, Sonal, et al.
Publicado: (2020)

1357. Patterns of Extragenital Gonorrhea and Chlamydia Testing at a Community-Based Academic Emergency Department in Columbus, Ohio
por: Magaña, Francisco M, et al.
Publicado: (2021)

610. Incidence of Acute Kidney Injury in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin
por: Hamad, Yasir, et al.
Publicado: (2020)

347. Development of an Electronic Medical Record-Based Outpatient Parenteral Antibiotic Therapy (OPAT) Tracking Dashboard
por: Bileck, Liddy, et al.
Publicado: (2023)

Outpatient Parenteral Antibiotic Therapy (OPAT) Serial Readmissions and High Utilizers: Drilling Down on Readmission Following Discharge on Intravenous Antibiotics
por: Andrews, Mary-Margaret, et al.
Publicado: (2017)

619. Quantifying the non-billable workload of Outpatient Parenteral Antibiotic Therapy (OPAT) services in a University Infectious Diseases (ID) Clinic
por: Burgoyne, Colleen, et al.
Publicado: (2020)

535. Comparison of Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Monoclonal Antibody Therapy (MAT) with Bamlamivimab or Casirivimab-Imdevimab
por: Nichols, Courtney, et al.
Publicado: (2021)

597. Comparison of Vancomycin and Daptomycin Complications and Interventions in Outpatient Parenteral Antimicrobial Therapy
por: Nakrani, Monark, et al.
Publicado: (2020)

608. Impact of Implementing Pharmacist Review and Monitoring of Outpatient Parenteral Antimicrobial Therapy
por: Kirkpatrick, Emily R, et al.
Publicado: (2020)

623. Self-Administered Outpatient Parenteral Antimicrobial Therapy (S-OPAT) in Uninsured Patients
por: Hamad, Yasir, et al.
Publicado: (2020)

129. Safety and Cost-effectiveness Analysis Outpatient Continuous Parenteral Antibiotics via a Disposable Elastomeric Pump at Two County Hospitals in Houston, Texas
por: Rao, Aishwarya, et al.
Publicado: (2021)

613. Clinical Outcomes Following Dalbavancin Administration during Outpatient Parenteral Antimicrobial Therapy
por: Tuan, Jessica, et al.
Publicado: (2021)

595. Characteristics of Antimicrobials Which Affect Parenteral Antibiotic Therapy Outcomes
por: Shah, haroon M, et al.
Publicado: (2020)

601. Assessment of a Nursing and Pharmacy Collaborative Outpatient Parenteral Antimicrobial Therapy Management Program
por: Hemenway, Alice N, et al.
Publicado: (2021)

608. Continuous Infusion Vancomycin Is Not Associated with Improved Safety in an Outpatient Parenteral Antimicrobial Therapy Program
por: Tagare, Rosemarie D, et al.
Publicado: (2021)

622. Evaluation of Vascular Access Device Selection in Patients Discharged on Outpatient Parenteral Antimicrobial Therapy
por: Hu, Jessica, et al.
Publicado: (2021)

Safety and Efficacy of Telavancin at an Outpatient Parenteral Antibiotic Therapy (OPAT) Unit in New York City
por: Rodriguez, George D, et al.
Publicado: (2017)

1758. Retrospective cohort analysis of outcomes in patients receiving outpatient parenteral antibiotic therapy (OPAT)
por: Billmeyer, Kaylyn, et al.
Publicado: (2022)

101. Serious Adverse Event Rates for Cefazolin and Ceftriaxone Outpatient Parenteral Antimicrobial Therapy
por: Sunagawa, Shawnalyn, et al.
Publicado: (2023)

604. Factors Associated with Adverse Drug Reactions Leading to Discontinuation of Vancomycin in Outpatient Parenteral Antimicrobial Therapy
por: McDonald, Josh, et al.
Publicado: (2020)

622. Risk Factors for 30-Day Unplanned Readmissions in Patients Discharged with Outpatient Parenteral Antimicrobial Therapy
por: Shah, Megan, et al.
Publicado: (2020)

126. evaluation of Addition of Outpatient Parenteral Antimicrobial Therapy and Orthopedic ID Resources to Transitions-of-care Outcomes
por: Young, Brett, et al.
Publicado: (2020)

1935. Outpatient Parenteral Antimicrobial Therapy in Nonagenarians
por: Blaskewicz, Caitlin, et al.
Publicado: (2018)

1940. Outcomes Among Patients Enrolled in an Outpatient Parenteral Antibiotic Therapy Program at an Academic Medical Center
por: Theodore, Deborah, et al.
Publicado: (2018)

1080. OPAT at the End of Life?: Short- and Long-Term Mortality Following Outpatient Parenteral Antibiotic Therapy
por: Schranz, Asher J, et al.
Publicado: (2019)

342. Evaluation of Patient Satisfaction with Outpatient Parenteral Antibiotic Therapy (OPAT) at a University Medical Center
por: Sawey, Ciara, et al.
Publicado: (2023)

351. Factors Predicting Readmission within 90 days in Patients Receiving Outpatient Parenteral Antibiotic Therapy
por: Smola, Kyle, et al.
Publicado: (2023)

602. Do These Labs Really Matter? Searching for the Benefit of Laboratory Monitoring in Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Zukauckas, Kelsea N, et al.
Publicado: (2020)

620. Identifying the Role for a Pharmacist on an Outpatient Parenteral Antimicrobial Therapy (OPAT) Team in an Academic Teaching Hospital
por: Hino, Garret H, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s7lufeuhm8rotg4c4g59009uqb